NCT02556463 2018-12-19A Study of MEDI9197 in Subjects With Solid Tumors or CTCL and in Combination With Durvalumab and/or Palliative Radiation in Subjects With Solid TumorsMedImmune LLCPhase 1 Terminated53 enrolled